These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36823036)

  • 1. Yellow Fever Vaccine-Associated Viscerotropic Disease among Siblings, São Paulo State, Brazil.
    Fernandes EG; Gomes Porto VB; de Oliveira PMN; Duarte-Neto AN; de Sousa Maia ML; Lignani LK; Nogueira JS; Teixeira GV; Iglezias SD; Blanco RM; Sato HK
    Emerg Infect Dis; 2023 Mar; 29(3):493-500. PubMed ID: 36823036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yellow fever vaccine usage in the United States and risk of neurotropic and viscerotropic disease: A retrospective cohort study using three healthcare databases.
    Ledlie S; Ricci C; Pan C; Rojas A; Khromava A; Li L
    Vaccine; 2022 Jan; 40(5):742-751. PubMed ID: 34996642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of yellow fever vaccine-associated viscerotropic disease among the elderly: a systematic review.
    Rafferty E; Duclos P; Yactayo S; Schuster M
    Vaccine; 2013 Dec; 31(49):5798-805. PubMed ID: 24079979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of the risks and benefits of yellow fever vaccination including some new analyses.
    Monath TP
    Expert Rev Vaccines; 2012 Apr; 11(4):427-48. PubMed ID: 22551029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: systematic review.
    Thomas RE; Lorenzetti DL; Spragins W; Jackson D; Williamson T
    Vaccine; 2011 Jun; 29(28):4544-55. PubMed ID: 21549787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse events following yellow fever preventive vaccination campaigns in eight African countries from 2007 to 2010.
    Breugelmans JG; Lewis RF; Agbenu E; Veit O; Jackson D; Domingo C; Böthe M; Perea W; Niedrig M; Gessner BD; Yactayo S;
    Vaccine; 2013 Apr; 31(14):1819-29. PubMed ID: 23395587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yellow fever vaccine-associated neurologic and viscerotropic disease: a 10-year case series of the French National Reference Center for Arboviruses with clinical and immunological insights.
    Le Hir A; Durand GA; Boucraut J; Garnier A; Mura M; Diamantis S; Carles M; Durand C; Schweitzer C; Audouard C; Decroix V; Boyez R; Van Dendriessche A; Leclancher A; Kaphan E; Barbat du Closel L; Verdon R; du Cheyron D; Vabret A; Vergnon D; Grard G; Charrel R; de Lamballerie X; Eldin C
    J Travel Med; 2024 Mar; 31(2):. PubMed ID: 38123499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viscerotropic disease following yellow fever vaccination in Peru.
    Whittembury A; Ramirez G; Hernández H; Ropero AM; Waterman S; Ticona M; Brinton M; Uchuya J; Gershman M; Toledo W; Staples E; Campos C; Martínez M; Chang GJ; Cabezas C; Lanciotti R; Zaki S; Montgomery JM; Monath T; Hayes E
    Vaccine; 2009 Oct; 27(43):5974-81. PubMed ID: 19679215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case suspected for yellow fever vaccine-associated viscerotropic disease in the Netherlands.
    van de Pol EM; Gisolf EH; Richter C
    J Travel Med; 2014; 21(6):421-4. PubMed ID: 24920138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinician's perspective on yellow fever vaccine-associated neurotropic disease.
    Lecomte E; Laureys G; Verbeke F; Domingo Carrasco C; Van Esbroeck M; Huits R
    J Travel Med; 2020 Nov; 27(7):. PubMed ID: 32965473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease.
    Belsher JL; Gay P; Brinton M; DellaValla J; Ridenour R; Lanciotti R; Perelygin A; Zaki S; Paddock C; Querec T; Zhu T; Pulendran B; Eidex RB; Hayes E
    Vaccine; 2007 Dec; 25(50):8480-5. PubMed ID: 18023511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First case of yellow fever vaccine-associated viscerotropic disease (YEL-AVD) in Hong Kong.
    Leung WS; Chan MC; Chik SH; Tsang TY
    J Travel Med; 2016 Apr; 23(4):. PubMed ID: 27087559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse event reports following yellow fever vaccination, 2007-13.
    Lindsey NP; Rabe IB; Miller ER; Fischer M; Staples JE
    J Travel Med; 2016 May; 23(5):. PubMed ID: 27378369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Usefulness of a Duplex RT-qPCR during the Recent Yellow Fever Brazilian Epidemic: Surveillance of Vaccine Adverse Events, Epizootics and Vectors.
    Queiroz ALN; Barros RS; Silva SP; Rodrigues DSG; Cruz ACR; Dos Santos FB; Vasconcelos PFC; Tesh RB; Nunes BTD; Medeiros DBA
    Pathogens; 2021 Jun; 10(6):. PubMed ID: 34204910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Bicistronic Yellow Fever Live Attenuated Vaccine with Reduced Neurovirulence and Viscerotropism.
    Wang HJ; Guo Y; He MJ; Liu ZY; Ye Q; Huang XY; Deng YQ; Li XF; Qin CF
    Microbiol Spectr; 2022 Oct; 10(5):e0224622. PubMed ID: 35980184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced safety surveillance of STAMARIL® yellow fever vaccine provided under the expanded access investigational new drug program in the USA.
    Rojas A; Hachey W; Kaur G; Korejwo J; Muhammad R
    J Travel Med; 2023 Nov; 30(7):. PubMed ID: 37000007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding yellow fever-associated myocardial injury: an autopsy study.
    Giugni FR; Aiello VD; Faria CS; Pour SZ; Cunha MDP; Giugni MV; Pinesi HT; Ledesma FL; Morais CE; Ho YL; Sztajnbok J; de Morais Fernezlian S; Ferraz da Silva LF; Mauad T; Ferreira Alves VA; Hilário do Nascimento Saldiva P; Antonangelo L; Dolhnikoff M; Duarte-Neto AN
    EBioMedicine; 2023 Oct; 96():104810. PubMed ID: 37757571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yellow fever vaccine-associated viscerotropic disease and death in Spain.
    Doblas A; Domingo C; Bae HG; Bohórquez CL; de Ory F; Niedrig M; Mora D; Carrasco FJ; Tenorio A
    J Clin Virol; 2006 Jun; 36(2):156-8. PubMed ID: 16597510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of the yellow Fever vaccine: a retrospective study.
    Nordin JD; Parker ED; Vazquez-Benitez G; Kharbanda EO; Naleway A; Marcy SM; Molitor B; Kuckler L; Baggs J
    J Travel Med; 2013; 20(6):368-73. PubMed ID: 24118538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next generation live-attenuated yellow fever vaccine candidate: Safety and immuno-efficacy in small animal models.
    Piras-Douce F; Raynal F; Raquin A; Girerd-Chambaz Y; Gautheron S; Sanchez MEN; Vangelisti M; Mantel N
    Vaccine; 2021 Mar; 39(13):1846-1856. PubMed ID: 33685778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.